Home › Research › Prevention and risk
Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases
Karolina Orywal, Katarzyna Socha, Piotr Iwaniuk, Piotr Kaczyński, Jakub Ali Farhan, Wojciech Zoń, Bożena Łozowicka, Maciej Perkowski et al.. International Journal of Molecular Sciences, 2025-02-04
Topic: Risk, prevention and care in population studies
Plain-language summary
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), which are a consequence of the progressive loss of neuronal function and structure, cause significant cognitive impairment. The incidence of these diseases in the world's population is constantly increasing as a result of an aging population. Although genetic and environmental factors are most often mentioned as the pathogenetic factors of these diseases, increasing evidence points to the important role of proper nutrition in the prevention and support of the treatment of these disorders. A healthy, balanced diet can mitigate the risks associated with the risk factors mentioned above and slow the progression of the disease by reducing oxidative stress and inflammation. Vitamins B, D, E, C, K, and A have been shown to support cognitive functions and protect the nervous system. This review demonstrates the importance of vitamins in preventing and supporting the therapy of neurodegenerative diseases. Information regarding the health-promoting properties of these vitamins must be effectively communicated to consumers seeking to protect their health, particularly in the context of neurodegenerative diseases. Consequently, this review also examines the authorized health claims under EU food law related to these vitamins, assessing their role in promoting awareness of the vitamins' potential benefits for neuroprotection and the management of neurodegenerative diseases.
What this study adds
Evidence grade: Low
This review discusses how vitamins B, D, E, C, K and A may support cognitive function and protect the nervous system, and how a healthy balanced diet might slow progression of neurodegenerative diseases including Alzheimer's by reducing oxidative stress and inflammation. It is a review of existing evidence rather than a trial, so it does not establish that vitamins prevent or treat Alzheimer's.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Orywal, K., Socha, K., Iwaniuk, P., Kaczyński, P., Farhan, J. A., Zoń, W., et al. (2025). Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031333
Vancouver
Orywal K, Socha K, Iwaniuk P, Kaczyński P, Farhan JA, Zoń W, et al. Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031333. PMID: 39941101.
BibTeX
@article{orywal2025-39941101,
author = {Orywal, Karolina and Socha, Katarzyna and Iwaniuk, Piotr and Kaczyński, Piotr and Farhan, Jakub Ali and Zoń, Wojciech and Łozowicka, Bożena and Perkowski, Maciej and others},
title = {{Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases}},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031333},
pmid = {39941101},
url = {https://doi.org/10.3390/ijms26031333}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), which are a consequence of the progressive loss of neuronal function and structure, cause significant cognitive impairment.
- The incidence of these diseases in the world's population is constantly increasing as a result of an aging population.
- A healthy, balanced diet can mitigate the risks associated with the risk factors mentioned above and slow the progression of the disease by reducing oxidative stress and inflammation.
Why it matters
This review discusses how vitamins B, D, E, C, K and A may support cognitive function and protect the nervous system, and how a healthy balanced diet might slow progression of neurodegenerative diseases including Alzheimer's by reducing oxidative stress and inflammation. It is a review of existing evidence rather than a trial, so it does not establish that vitamins prevent or treat Alzheimer's.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Molecular Sciences) |
| Journal's citation record | 3 / 4 | International Journal of Molecular Sciences: journal h-index 426 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 38 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 12.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 11.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 38 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Barbara Mroczko: h-index 50 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Medical University of Białystok: institution h-index 260 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39941101) |
| Free to read | 2 / 2 | Free to read |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/ijms26031333
- PubMed: 39941101
- Original source →
- Free full text: International Journal of Molecular Sciences →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
265 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.